TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Activity

452 hedge funds and large institutions have $5.91B invested in Teva Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 160 increasing their positions, 137 reducing their positions, and 110 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
452
Holders Change
-69
Holders Change %
-13.24%
% of All Funds
9.83%
Holding in Top 10
6
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-53.85%
% of All Funds
0.13%
New
46
Increased
160
Reduced
137
Closed
110
Calls
$255M
Puts
$309M
Net Calls
-$54.5M
Net Calls Change
-$19.6M

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$66.1M
2
Morgan Stanley
Morgan Stanley
New York
+$47.4M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$41M
4
CS
Credit Suisse
Switzerland
+$37.2M
5
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$32.6M

Top Sellers

1
BC
Brahman Capital
New York
-$111M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$101M
3
HCM
Highfields Capital Management
Massachusetts
-$83M
4
PCM
Polaris Capital Management
Massachusetts
-$70.1M
5
Capital World Investors
Capital World Investors
California
-$64.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.21B +$24.9M +2,700,837 +2%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$581M +$41M +4,437,282 +8%
Franklin Resources
3
Franklin Resources
California
$569M -$27.5M -2,980,753 -5%
Berkshire Hathaway
4
Berkshire Hathaway
Nebraska
$399M – – –
Capital World Investors
5
Capital World Investors
California
$366M -$64.8M -7,023,189 -15%
BlackRock
6
BlackRock
New York
$323M +$10.9M +1,175,800 +3%
ACM
7
Abrams Capital Management
Massachusetts
$167M – – –
State Street
8
State Street
Massachusetts
$116M +$18.1M +1,960,758 +18%
Renaissance Technologies
9
Renaissance Technologies
New York
$90.3M +$66.1M +7,159,900 +273%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$88.2M +$14.7M +1,593,139 +20%
Norges Bank
11
Norges Bank
Norway
$76.3M -$8.69M -941,020 -10%
Northern Trust
12
Northern Trust
Illinois
$70.2M +$7.81M +846,650 +13%
CS
13
Credit Suisse
Switzerland
$66.2M +$37.2M +4,029,506 +128%
AllianceBernstein
14
AllianceBernstein
Tennessee
$64.9M -$54.3M -5,878,746 -46%
Morgan Stanley
15
Morgan Stanley
New York
$64.7M +$47.4M +5,140,764 +276%
MVP
16
Miller Value Partners
Florida
$60M +$18.1M +1,957,720 +43%
CCM
17
Camber Capital Management
Massachusetts
$60M +$27.7M +3,000,000 +86%
DG
18
Delek Group
Israel
$57.4M +$11.1M +1,230,259 +24%
Fidelity Investments
19
Fidelity Investments
Massachusetts
$56.3M -$101M -10,968,226 -64%
CA
20
Commerzbank Aktiengesellschaft
Germany
$51.9M +$31.5M +3,412,966 +155%
HIIFS
21
Harel Insurance Investments & Financial Services
Israel
$49.4M +$246K +26,600 +0.5%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$44.9M +$13.4M +1,453,617 +43%
Deutsche Bank
23
Deutsche Bank
Germany
$43.7M +$28.9M +3,127,190 +195%
JPMorgan Chase & Co
24
JPMorgan Chase & Co
New York
$38.7M +$17M +1,875,195 +79%
Sumitomo Mitsui Trust Group
25
Sumitomo Mitsui Trust Group
Japan
$37M +$4.23M +458,751 +13%
1
2 3 4 5